Potential factors affecting adherence with HIV therapy

[1] ARNOLD RJG, 1993, SOUTHERN MED J, V86, P208

[2] BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121

[3] CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037/0278-6133.14.1.88

[4] *CDCP, 1996, HIV AIDS SURV REP JU

[5] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P733

[6] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P121

[7] FAILURE OF ANTIRETROVIRAL THERAPY - ROLE OF VIRAL AND CELLULAR FACTORS [J]. INTERVIROLOGY, 1994, 37 (06) : 307 - 314

[8] COONS SJ, 1994, CLIN THER, V16, P110

[9] PHARMACOKINETIC ADVANTAGES OF ERYTHROMYCIN ESTOLATE OVER ETHYLSUCCINATE AS DETERMINED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) : 561 - 565

[10] DANIELS DE, 1994, J NATL MED ASSOC, V86, P20

[1] ARNOLD RJG, 1993, SOUTHERN MED J, V86, P208

[2] BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121

[3] CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037/0278-6133.14.1.88

[4] *CDCP, 1996, HIV AIDS SURV REP JU

[5] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P733

[6] *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P121

[7] FAILURE OF ANTIRETROVIRAL THERAPY - ROLE OF VIRAL AND CELLULAR FACTORS [J]. INTERVIROLOGY, 1994, 37 (06) : 307 - 314

[8] COONS SJ, 1994, CLIN THER, V16, P110

[9] PHARMACOKINETIC ADVANTAGES OF ERYTHROMYCIN ESTOLATE OVER ETHYLSUCCINATE AS DETERMINED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) : 561 - 565

[10] DANIELS DE, 1994, J NATL MED ASSOC, V86, P20